Displaying 61 - 80 of 1567
FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal
Premerger Notification; Reporting and Waiting Period Requirements; Notice of Extension of Public Comment Period
FTC and DOJ Extend Public Comment Period by 30 Days on Proposed Changes to HSR Form
Statement Regarding Termination of CooperCompanies’ Attempted Acquisition of Cook Medical’s Reproductive Health Business
Statement Of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines
FTC and DOJ Seek Comment on Draft Merger Guidelines
FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising
Altria Group/JUUL Labs, In the Matter of
The Federal Trade Commission filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws. According to the complaint, this series of agreements involved Altria ceasing to compete in the U.S. market for closed-system electronic cigarettes in return for a substantial ownership interest in JUUL, by far the dominant player in that market. In an initial decision announced on Feb. 24, 2022, Chief Administrative Law Judge D. Michael Chappell dismissed the antitrust charges in the complaint.
16 CFR Parts 801 and 803: Premerger Notification; Reporting and Waiting Period Requirements
FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review
FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Displaying 61 - 80 of 1567